Australia and New Zealand Summit 2022
As stakeholders navigate ‘The Great Reset’ in clinical research and the continued momentum toward decentralization, it’s important to integrate the learnings from the past two years operating in a mostly hybrid and/or decentralized trial approach into best practice. Lessons gleaned can improve traditional, hybrid and decentralized trial approaches and enable our industry to coalesce around universally high-quality standards and scientific rigor while creating a strong foundation for sites and sponsors to mature their decentralization efforts in 2022 and beyond.
At Syneos Health, it’s our business to understand how sites work. Because when we understand the issues sites face, we can better accelerate success. Through our Site Advisor Groups and Catalyst Site Community in APAC, we take the time to cultivate meaningful connections with investigators from the start and help adapt best practices to the unique APAC landscape.
Here to learn more about Illingworth Research Group, a Syneos Health company?
Mobile research nursing, patient concierge, medical imaging, clinical services and more
Want to learn more? Access our full website here, explore Insights Hub for the latest industry perspectives, subscribe to our podcast, or click on the resources below:
- WEBINAR: How Technology Can Drive Diverse Representation and a Retention-Boosting Patient Experience for Clinical Trials
- VIDEO: Adoption of Decentralized and Patient-Centric Clinical Trial Approaches on the Global Stage
- WEBINAR: Preparing for Implementation of Decentralized Clinical Trials in APAC
- Hybrid Decentralized Trials in Oncology: A Path to Diversity
- It’s Time for Oncology Trials to Transition to Risk-Based Monitoring
- Site Relationships and Catalyst Program
- Increase Predictability of Clinical Trial Delivery – About Our Catalyst Site Network
- About Syneos Health Decentralized Solutions
